Daily Health Headlines

Parkinson's Drug Shows Promise Against Macular Degeneration

👤by Randy Dotinga 0 comments 🕔Friday, November 13th, 2015

THURSDAY, Nov. 12, 2015 (HealthDay News) -- A common Parkinson's disease medication might hold potential for preventing or treating macular degeneration, the leading cause of vision loss in the elderly, new research suggests.

At this stage, no one is recommending that patients take the drug, levodopa (L-dopa), to thwart eye disease. But the findings are intriguing, researchers said.

"Patients taking L-dopa for any reason are much less likely to develop age-related macular degeneration. If they do, they develop the disease much later in life than those not taking L-dopa," said study lead author Brian McKay, an associate professor of ophthalmology and vision science at the University of Arizona.

However, the study doesn't actually prove that levodopa causes a lower incidence of age-related macular degeneration. It only uncovered an association between the two.

Age-related macular degeneration affects about 30 percent of those older than 75, McKay said. It is caused by deterioration of the macula, the center part of the retina, and by affecting vision, it can severely limit the ability to perform everyday activities. Treatments can slow its progression but there is no cure, and it can lead to blindness.

"This disease robs people of close vision," McKay said. A preventive treatment "will allow many to see their families and grandchildren as they age, and allow the aging population to keep their independence and drive, read, cook and watch TV," he said.

In the body, levodopa turns into dopamine, a naturally occurring chemical that appears linked to normal function of the retina, McKay said. In Parkinson's, insufficient dopamine contributes to movement problems.

For the study, researchers analyzed medical records of 37,000 patients from a Wisconsin clinic. The researchers looked for signs whether or not those who took levodopa had lower rates of age-related macular degeneration. They also examined a medical database of 87 million people.

The researchers found that diagnosis of age-related macular degeneration occurred, in general, around age 71. But among those who took levodopa, it occurred much later, at around age 79.

According to McKay, the drug may affect development of age-related macular degeneration by protecting parts of the eye known as photoreceptors. These neurons help the body sense light.

Levodopa, however, might not be the major player here. It's possible, McKay said, that Parkinson's disease itself could reduce the risk of age-related macular degeneration. Or there could be another scenario.

McKay mentioned that having red hair is linked to higher risks of both Parkinson's disease and age-related macular degeneration. This suggests a connection. "I am not sure the diseases are completely independent," he said.

In Parkinson's patients, levodopa causes side effects such as nausea and low blood pressure, but McKay said side effects in people without Parkinson's are unknown. He said the drug is sold over the counter and taken by body builders, among others.

Levodopa is inexpensive, and that may be a big problem, said Dr. Paul Bernstein, a professor of ophthalmology and visual sciences at the University of Utah School of Medicine. He wasn't involved with the study.

Since it's cheap, "many drug companies won't be interested in repurposing it," he said, noting that could spell trouble for research.

Bernstein also cautioned that this study doesn't confirm that levodopa will help people with age-related macular degeneration or those at risk for developing it.

"This is a first step," Bernstein said. "It may point to doing future studies. But I wouldn't recommend that my patients take L-dopa now. It could be dangerous."

If future research proves it is effective against macular degeneration, the drug potentially could be used to treat or prevent the condition, although it's unlikely to reverse existing eye damage, McKay said.

It's unclear when clinical trials would take place.

What causes macular degeneration is unknown, although genetics, being overweight and smoking are thought to play a role, according to the American Macular Degeneration Foundation. Whites are more vulnerable than blacks and Hispanics to the condition.

The study was published Nov. 9 in the American Journal of Medicine.

Article Credits / Source

Randy Dotinga / HealthDay

Randy Dotinga wrote this story for HealthDay. HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

SOURCES: Brian S. McKay, Ph.D., associate professor, ophthalmology and vision science, University of Arizona, Tucson; Paul Bernstein, M.D., Ph.D., professor, ophthalmology and visual sciences, Moran Eye Center, University of Utah School of Medicine, Salt Lake City; Nov. 9, 2015, American Journal of Medicine

View More Articles From Randy Dotinga 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More Eyesight Articles

Doctors Use iPads to Treat 'Lazy Eye,' With Mixed Results

Doctors Use iPads to Treat 'Lazy Eye,' With Mixed Results0

THURSDAY, Nov. 10, 2016 (HealthDay News) -- Does playing video games on an iPad work better than standard eye-patching for improving vision in children with lazy eye? Two new studies in the journal JAMA Ophthalmology reach seemingly ...

Some Primates Have Vision Troubles as They Age

Some Primates Have Vision Troubles as They Age0

TUESDAY, Nov. 8, 2016 (HealthDay News) -- Just like humans, some primates start having difficulty seeing things up close as they age. Researchers reviewed photos of 14 wild bonobos as they groomed each other. The primates were between 11 and 45 ...

Paintball Causes Many Vision-Robbing Eye Injuries

Paintball Causes Many Vision-Robbing Eye Injuries0

THURSDAY, Nov. 4, 2016 (HealthDay News) -- Paintball guns pose the greatest risk of vision loss among the sports most commonly associated with eye injuries, a new study finds. Basketball, cycling and baseball injuries to the eye occur more ...

Health Tip: Are Your Screens Causing Eye Strain?

Health Tip: Are Your Screens Causing Eye Strain?0

(HealthDay News) -- Staring at your TV, computer, smart phone or tablet can cause a problem known as computer vision syndrome, or digital eye strain. The American Optometric Association says to watch for these warning signs: Feeling that ...

Mediterranean Diet, Caffeine May Be Good for Your Eyes

Mediterranean Diet, Caffeine May Be Good for Your Eyes0

THURSDAY, Oct. 20, 2016 (HealthDay News) -- Eating a Mediterranean diet and consuming caffeine may lower your chances of developing age-related macular degeneration (AMD), a leading cause of blindness, according to a new study. Previous ...

View More Eyesight Articles

0 Comments

Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!